Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.

BGF UK Enterprise Fund 2 LP investment portfolio

BGF UK Enterprise Fund 2 LP has made numerous investments in companies such as Maxion Therapeutics, Enhanced Genomics, and Makers Academy within the Healthcare & Life Sciences sector.

vc
Portfolio
8
Team
0

Ownership Chain

Sign up free to see the Persons with Significant Control resolved from Companies House.

Sign up free

Portfolio (8)

CompanySectorCitySourceLast confirmed on
Enhanced Genomics Limited
Enhanced Genomics provides a 3D multi‑omics platform (GenLink™) that maps genome folding and integrates omics data to uncover causal biological networks, enabling pharmaceutical and biotech partners to discover and validate therapeutic targets, while also operating its own in‑house target‑discovery programmes for diseases with significant unmet need.
Healthcare & Life SciencesCambridgeConfirmed2026-02-03
Gaussion Ltd
Gaussion develops magneto‑electrochemical technology that enables ultrafast, safe charging of electric‑vehicle batteries while reducing degradation, and provides an intelligent control layer for battery packs.
Healthcare & Life SciencesLondonConfirmed2025-07-26

Sign up to see the full portfolio

+6 more companies

Sign up

Backs Similar Companies

Investors who tend to invest in the same sort of companies.

5 more similar investors hiddenSign up to unlock →

Shareholding changes (7)

Bgf Ukef 2 Nominees Limited (A/C Bgf Uk Enterprise Fund 2 Lp)'s positions across portfolio companies
2026
  • 07-26ChangedGaussion Ltd
    • SERIES A PREFERRED 21,1830
    • SERIES A -1 PREFERRED 021,183
    • SERIES A-2 PREFERRED 034,374
    • A ORDINARY 053,069
    • A2 ORDINARY 052,707

Sign up free to see when this investor has bought or sold shares.

+5 more changes

Sign up

Articles (1)